Detalles de la búsqueda
1.
Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial.
Lancet
; 401(10378): 733-746, 2023 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36764316
2.
Reporting of interventional clinical trial results in an academic center: a survey of completed studies.
BMC Med Res Methodol
; 24(1): 93, 2024 Apr 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38649798
3.
A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT-0701 MAPS phase 3 trial.
Int J Cancer
; 150(11): 1889-1904, 2022 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35262190
4.
Carboplatin plus etoposide versus topotecan as second-line treatment for patients with sensitive relapsed small-cell lung cancer: an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 21(9): 1224-1233, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32888454
5.
First-line carboplatin plus pemetrexed with pemetrexed maintenance in HIV-positive patients with advanced non-squamous non-small cell lung cancer: the phase II IFCT-1001 CHIVA trial.
Eur Respir J
; 56(2)2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32444410
6.
Open-label Phase II trial to evaluate safety and efficacy of second-line metronomic oral vinorelbine-atezolizumab combination for stage-IV non-small-cell lung cancer - VinMetAtezo trial, (GFPC 04-2017).
Future Oncol
; 16(4): 5-10, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31894704
7.
Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.
Lancet Oncol
; 19(4): 521-536, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29545095
8.
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
N Engl J Med
; 373(17): 1627-39, 2015 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-26412456
9.
Cost-effectiveness of KRAS, EGFR and ALK testing for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study.
Eur Respir J
; 51(3)2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29545318
10.
Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 18(12): 1652-1664, 2017 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-29074099
11.
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT).
Lancet
; 387(10026): 1415-1426, 2016 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-26777916
12.
TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial.
Lancet Oncol
; 17(2): 212-223, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26727163
13.
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial.
Lancet Oncol
; 16(3): 257-65, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25704439
14.
Cost-utility analysis of maintenance therapy with gemcitabine or erlotinib vs observation with predefined second-line treatment after cisplatin-gemcitabine induction chemotherapy for advanced NSCLC: IFCT-GFPC 0502-Eco phase III study.
BMC Cancer
; 14: 953, 2014 Dec 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25511923
15.
A phase I, open-label, single-arm study for QT assessment of eribulin mesylate in patients with advanced solid tumors.
Invest New Drugs
; 31(4): 900-9, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23143778
16.
Enrolment of older adults with advanced or metastatic non-small cell lung cancer in first-line clinical trials in the multicentre ESME cohort.
J Geriatr Oncol
; 14(2): 101423, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36657245
17.
Treatment patterns and clinical outcomes of extensive stage small cell lung cancer (SCLC) in the real-world evidence ESME cohort before the era of immunotherapy.
Respir Med Res
; 84: 101012, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37307617
18.
VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial.
Lung Cancer
; 182: 107287, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37393757
19.
Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial.
Lancet Oncol
; 12(12): 1125-33, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22019520
20.
Preclinical Models for Acquired Resistance to Third-Generation EGFR Inhibitors in NSCLC: Functional Studies and Drug Combinations Used to Overcome Resistance.
Front Oncol
; 12: 853501, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35463360